Skip to main content
Trauma Prevention and Outreach

Trauma Prevention and Outreach

NEWS | November 28, 2011

Long-time professor and hemophilia expert receives national honor

(SACRAMENTO, Calif.)

Jerry Powell, professor of hematology and oncology and director of the UC Davis Hemophilia and Thrombosis Treatment Center, has been awarded "Physician of the Year" by the National Hemophilia Foundation.

The Award of Excellence, announced at the organization's 63rd annual meeting in Chicago earlier this month, recognizes "remarkable and distinguished individuals in the bleeding and clotting disorders community."

Dr. Powell © UC Regents
Dr. Jerry Powell

Powell, who has been with UC Davis since 1990, has been instrumental in helping develop new treatments in hemophilia, hepatitis, HIV, inhibitors and von Willebrand disease, and is an author on more than 60 peer-reviewed articles.

"The true barometer of any physician is how ones' patients regard you, and Dr. Powell is trusted, respected, and well-loved by his patients," said Sean Hubbert, president of the Central California Hemophilia Foundation, which nominated Powell for the award.

An active board member for the Central California Hemophilia Foundation for 22 years, Powell has collaborated on numerous region-wide patient studies for the investigation of bleeding disorders.

The National Hemophilia Foundation is dedicated to finding better treatments and cures for bleeding and clotting disorders and preventing complications of the disorders through education, advocacy and research. The national foundation has chapters throughout the country.

Through the efforts of the hemophilia community and the treatment centers like the one at UC Davis, the life expectancy of a child born with severe hemophilia has increased dramatically in the past 30 years. A hemophilic child born in 1960 was expected to live only 15-20 years. That same child born in 2000 can expect to live a nearly normal life span of 79 years. For patients with hemophilia, use of treatment center services in the 1990s has been shown to reduce mortality by 40 percent.

About the UC Davis Hemophilia Treatment Center
The UC Davis Hemophilia Treatment Center is a federally funded, registered hemophilia treatment center offering comprehensive medical, psychosocial and specialty care to persons with hemophilia and related bleeding disorders.  Part of a national network, the center provides medical, educational and social resources to people with hemophilia and other inherited bleeding disorders, their families, health care providers, and the community.